Skip to main content
Premium Trial:

Request an Annual Quote

Stilla Technologies Prism Six-Color Digital PCR System

Stilla Technologies has launched the Prism digital PCR system featuring six-color detection capability. The system builds upon the company's current three-color Naica digital PCR system and has been validated for use with a six-color lung cancer panel for EGFR mutation quantification in liquid biopsy-based monitoring in breast and rectal cancer. The company first described the six-color workflow for non-small cell lung cancer mutations in a proof-of-concept study published last year, and replicated the approach to validate the breast and rectal cancer panels.

The system has also been validated for use with a panel for detecting and quantifying genetically modified organisms in the food supply, the company said. The new system can provide results in under three hours, uses the same workflow as the Naica system, and is compatible with current Stilla consumables.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.